medica conf, page-16

I support your optimism Microkosmos,
The recent buying at around 5 to 6 mil per day show increased interest in our compelling story and I would expect the share to break out of its current trading range, in which it is artificially trapped by active bot trading, into the range of 7 to 8 cents as previously anticipated by me about a week ago.


ADO should ride the wave of excitement in the market about the enormous returns biotechs offer in this difficult investment environment and many investors move from resource driven portfolios into a more diverse investments with many bios on the radar.


Fundamentaly, we are overdue for a signature.
Our estimate that pipeline extensions for our testing program pushed a decision by the large IVD company out by half a year would make early next year an exciting time.
Market should, particularly given the reasons mentioned above, start to appreciate that outlook.

I maintain my sentiment that Medica marked the turnaround for our shareprice sentiment.

ADO is a strong at buy at current levels.